Quality-of-life (QoL) measures in advanced non-small cell lung cancer (NSCLC) patients and their association with treatment choices across 5 European countries: Preliminary data from the ACTION study

被引：0

作者：

Pimental, F

Szczepura, A

Thomas, M

Frimodt-Moller, B

Belger, M

Watkins, J

Watt, M

机构：

[1] Hosp Sao Sebastiao, Sao Sebastian, Portugal

[2] Warwick Medcl Sch, Coventry, W Midlands, England

[3] Univ Munster, D-4400 Munster, Germany

[4] Eli Lilly & Co, Copenhagen, Denmark

[5] Eli Lilly & Co, Windlesham, Surrey, England

[6] Eli Lilly & Co, Basingstoke, Hants, England

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：749S / 749S

页数：1